Acute and long-term results of the dose ranging double-blind olanzapine trial

Trân, Pierre V.; Beasley, C.; Tollefson, G.D.; Crawford, A.M.; Dellva, Mary Anne; Gusman, S.; Wood, Adynel

doi:10.1016/0924-977x(96)87573-0

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1997

2024

Publication Types

Select...

Article4

Book1

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 7 publications

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Olanzapine for schizophrenia

Duggan

Fenton

Rathbone

et al. 2005

Cochrane Database of Systematic Reviews

152

View full text Add to dashboard Cite

BackgroundOlanzapine is an atypical antipsychotic reported to be effective without producing disabling extrapyramidal adverse effects associated with older, typical antipsychotic drugs. ObjectivesTo determine the clinical effects and safety of olanzapine compared with placebo, typical and other atypical antipsychotic drugs for schizophrenia and schizophreniform psychoses. Search methodsWe updated the first search [

show abstract